Stop Worrying, Learn to Let Go Through a Combination of Neurostimulation and Psychotherapy
Led by University Hospital, Ghent · Updated on 2026-03-12
85
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
Researchers are investigating whether combining transcranial Direct Current Stimulation (tDCS) with cognitive-behavioral therapy (CBT) improves treatment for repetitive negative thinking (RNT) in patients who experience high levels of rumination. This study includes patients with generalized anxiety disorder or depressive disorder and compares active tDCS combined with CBT to sham (inactive) tDCS combined with CBT to evaluate their therapeutic effects.
The study has two stages. In the first stage, participants attend weekly CBT group sessions called "Drop It" for 7 weeks, each followed by either active or sham tDCS applied for 30 minutes. In the second stage, after these sessions, participants use the tDCS devices at home daily for 4 weeks, continuing with either active or sham stimulation, then return for a final CBT session. Neuroimaging scans (EEG and fNIRS) are done at the start and after 3 months of therapy to measure brain activity.
During the study, participants complete questionnaires assessing worry, depression, anxiety, and quality of life at baseline, after the therapy course, and at 3-month follow-up. Psychiatrists also evaluate participants at these points. Questionnaires measuring rumination are completed after each session. The main outcomes are the therapeutic effect of the combination therapy and the lasting impact of tDCS on CBT benefits, with safety and brain activity monitored over up to 3 months. Participation lasts approximately 3 months.
CONDITIONS
Brief Title
Combination of Neurostimulation and Psychotherapy to Stop Worrying
Who Can Participate
Age: 18Years - 70Years
All Genders
Eligibility Criteria
You may qualify if you...
Adults aged 18 to 70 years
Diagnosis of generalized anxiety disorder (GAD)
Diagnosis of depressive disorder
Ability to commit to 8 sessions of cognitive-behavioral therapy (CBT)
Ability to receive 4 weeks of transcranial Direct Current Stimulation (tDCS)
Sufficient knowledge of Dutch language
You will not qualify if you...
Presence of psychiatric disorders other than GAD or depression as assessed by a senior psychiatrist
Abuse of alcohol, drugs, or medications not prescribed by a doctor
Lack of consent to participate in measurements such as questionnaires, fNIRS, or EEG
Acute or chronic suicidality
Acute psychosis or manic depressive disorder
Inability to commit to the full therapy and stimulation schedule
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 7 weeks
Participants attend weekly cognitive-behavioral therapy (CBT) sessions for 7 weeks. After each session, they receive either active or sham transcranial Direct Current Stimulation (tDCS) for 30 minutes.
7 weekly visits (in-person)
Treatment
Duration - 4 weeks
Participants apply daily home-based active or sham tDCS for 4 weeks following the initial 7 CBT sessions.
Daily home-based stimulation
Treatment
Duration - 1 day
Participants return to the university hospital for the final CBT session after completing home-based tDCS.
1 visit (in-person)
Follow-up
Duration - 3 months from baseline
Participants complete questionnaires and undergo EEG and fNIRS neuroimaging to evaluate therapeutic effects at 3 months after starting therapy.
Cognitive behavioral based group psychotherapy focusing on repetitive negative thinking: Decreased uncontrollability of rumination is related to brain perfusion increases in the left dorsolateral prefrontal cortex.